See also this year's filing and all EDGAR filings for this company.
PDF Report 0001175505_2018_FIVE_Prime_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001175505, FIVE Prime Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 311,190,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 30,762,000 |
| 3 | remainder_Assets | 2,095,000 |
| 4 | LiabilitiesCurrent | 50,981,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 40,002,000 |
| 9 | ResearchAndDevelopmentExpense | 150,908,000 |
| 10 | remainder_Expenses | 1,798,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 42,486,000 |
| 13 | remainder_ComprehensiveNetIncome | -437,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 344,047,000 |
| 1 | Liabilities | 50,981,000 |
| 2 | Expenses | 192,708,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 293,066,000 |
| 5 | NetIncome | -150,222,000 |
| 6 | ComprehensiveNetIncome | -150,440,500 |
| 7 | BaseVar | 315,329,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.47 |
| 9 | EconomicCapitalRatio | 3.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
